Will Eli Lilly publish data on orforglipron by June 30, 2025?

Will Eli Lilly's orforglipron pill get FDA approval by March 31, 2026?

Will Stoke Therapeutics enter Phase 3 trials for Dravet syndrome treatment by end of 2025?

Will Biogen acquire Sage Therapeutics at $7.22 per share by June 30, 2025?

Will Biogen announce another biotech acquisition besides Sage by end of 2025?

How will Sage Therapeutics stock move by March 31, 2025, after Biogen acquisition proposal?

Will Sage Therapeutics' stock price rise by 20% or more by March 31, 2025?

Will Biogen acquire Sage Therapeutics by June 30, 2025?

Biogen's stock performance relative to the biotech index by end of 2025

Main competitive advantage of orforglipron by end of 2026

Will orforglipron surpass Eli Lilly's injectables in popularity by end of 2026?

Regulatory outcome for orforglipron by end of 2026

Weight-loss drug market share distribution by end of 2026

Who will be Biogen's next acquisition target in the biotech sector by end of 2025?

What will be the outcome of Biogen's acquisition proposal for Sage by end of 2025?

Outcome of Biogen's biotech acquisition attempts by end of 2025

Will Biogen announce a biotech acquisition over $500 million in 2025?

Biogen's primary acquisition target type in 2025